← Leaderboards
Harvey D Homan
Urovalve, Inc.
$1,513,577
Attributed
$1,513,577
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $502.3K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,513,577 · 2
By mechanism
R44$1,113,623 · 1
R43$399,954 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Patient Care”
- Larry Arthur$257,720,406
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$246,927,093
- Peter C Adamson · National Childhood Cancer Foundation$235,209,848
- Gregory H Reaman · National Childhood Cancer Foundation$183,240,392
- David Heimbrook · Leidos Biomedical Research, Inc.$181,149,360
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
Patient CareClinicTechnologyCharacteristicsInnovationPerformancePatternSmall Business Innovation Research GrantCost EffectivenessContractsCross-Over StudiesBladderBladder CalculiCostDevicesClinical ResearchCaregiversCollaborationsChronicAcuteCaringCase Report FormConsent FormsCompare Effectiveness
Grant awards (4)
Epithelial-Mesenchymal Transition Signature Markers (EMTsm) with Machine Learning-Based Analysis as a Predictor of Metastatic Prostate Cancer$399,954
R43 · FY2025 · CA · contact PI
Disposable Valved Intraurethral Catheter Feasibility$370,875
R44 · FY2010 · HD · contact PI
Disposable Valved Intraurethral Catheter Feasibility$240,460
R44 · FY2008 · HD · contact PI
Disposable Valved Intraurethral Catheter Feasibility$502,288
R44 · FY2007 · HD · contact PI